Genmab A/S
GMAB
$25.10
$0.301.21%
NASDAQ
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 53.00M | 31.00M | 336.00M | 336.00M | 195.00M |
| Total Depreciation and Amortization | 19.00M | 15.00M | 12.00M | 16.00M | 16.00M |
| Total Amortization of Deferred Charges | 29.00M | 6.00M | 4.00M | -- | -- |
| Total Other Non-Cash Items | 15.00M | -4.00M | -185.00M | -185.00M | 1.00M |
| Change in Net Operating Assets | -113.00M | 253.00M | -105.00M | -105.00M | 75.00M |
| Cash from Operations | 3.00M | 301.00M | 62.00M | 62.00M | 287.00M |
| Capital Expenditure | -5.00M | -13.00M | -10.00M | -10.00M | -12.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -7.22B | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.00M | 1.66B | 36.00M | 36.00M | -31.00M |
| Cash from Investing | -9.00M | -5.57B | 26.00M | 26.00M | -43.00M |
| Total Debt Issued | -- | 5.50B | -- | -- | -- |
| Total Debt Repaid | -69.00M | -2.00M | -4.00M | -4.00M | -2.00M |
| Issuance of Common Stock | 2.00M | 7.00M | 6.00M | 6.00M | 1.00M |
| Repurchase of Common Stock | -110.00M | -3.00M | -408.00M | -408.00M | -12.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -273.00M | -- | -- | -- |
| Cash from Financing | -177.00M | 5.23B | -406.00M | -406.00M | -13.00M |
| Foreign Exchange rate Adjustments | -11.00M | -4.00M | -5.00M | -5.00M | 8.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -194.00M | -46.00M | -323.00M | -323.00M | 239.00M |